Drug Coverage Lookup

See how a prescription drug is placed across Medicare Part D plan formularies — tier, prior authorization, step therapy, and quantity limits, counted per unique plan.

XIGDUO (Dapagliflozin and Metformin)

On Part D plan formularies

Found on the formularies of 5203 of 5499 Medicare Part D plans in this dataset · Tiers 1–6 · step therapy on 1 (0%) · quantity limits on 5068 (97%), counting a plan when at least one form/strength carries the flag.

This is dataset-wide formulary placement (data current through 2026-08-31) — check your specific plan for its current coverage and restrictions.

Found on the formularies of 5203 of 5499 Medicare Part D plans in this dataset (Tiers 1–6). Check your specific plan for its tier and copay — a low tier does not always beat a discount card.
Compare cash & discount prices →
PlanTierPrior AuthStep TherapyQty Limit
Hamaspik Medicare Choice (HMO D-SNP) (H0034-002) (NY) Tier 1 No No 60 per 30 days
VIVA Medicare Plus (HMO) (H0154-015) (segment 1) (AL) Tiers 1–3 No No 60 per 30 days
VIVA Medicare Plus (HMO) (H0154-015) (segment 2) (AL) Tiers 1–3 No No 60 per 30 days
VIVA Medicare Classic (HMO) (H0154-017) (AL) Tiers 1–3 No No 60 per 30 days
VIVA Medicare Infirmary Health Advantage (HMO) (H0154-020) (AL) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0354-001) (AZ) Tiers 1–3 No No 60 per 30 days
HealthSpring Alliance (HMO) (H0354-028) (AZ) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred Savings (HMO) (H0354-029) (AZ) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred Full Savings (HMO) (H0354-030) (AZ) Tiers 1–3 No No 60 per 30 days
DEVOTED CHOICE 001 DE (PPO) (H0413-001) (DE) Tiers 1–3 No No 60 per 30 days
DEVOTED CHOICE GIVEBACK 002 DE (PPO) (H0413-002) (DE) Tiers 1–3 No No 60 per 30 days
MetroPlus Advantage Plan (HMO D-SNP) (H0423-001) (NY) Tiers 1–3 No No 60 per 30 days
MetroPlus UltraCare (HMO D-SNP) (H0423-007) (NY) Tier 1 No No 60 per 30 days
HealthSpring Preferred GA (HMO) (H0439-003) (segment 1) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-008) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-009) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-010) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-011) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring TotalCare Plus (HMO D-SNP) (H0439-012) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-013) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-015) (segment 1) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred (HMO) (H0439-015) (segment 2) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred Savings (HMO) (H0439-016) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred Savings (HMO) (H0439-017) (GA) Tiers 1–3 No No 60 per 30 days
HealthSpring Preferred Savings (HMO) (H0439-018) (GA) Tiers 1–3 No No 60 per 30 days

One row per plan — showing 25 of 5203 plans; a Yes means the flag applies to at least one form/strength on that plan.

Acquisition cost (NADAC): $19.20043/unit — price effective 08/19/2026

For benefits professionals
Plan sponsors and advisors: formulary-placement and utilization analysis across plans.
For benefits teams: plan formulary analysis →

Source: CMS Monthly Prescription Drug Plan Formulary and Pharmacy Network Information — data current through 2026-08-31 (CMS release 2026-08-26, refreshed monthly) · NADAC price effective 08/19/2026 (per-NDC last change, not a data-staleness date). Dataset-wide plan-year formulary placement, not a guarantee of your individual benefit — confirm with your plan or pharmacist.

Data: CMS Monthly Part D formulary files · FDA/RxNorm drug identity · CMS NADAC pricing — CMS Part D formulary data current through 2026-08-31 · source

Machine access — this tool is available as structured data for AI assistants and agents:
GET https://insurewith.ai/tools/drug-coverage/data.json?drug=dapagliflozin-and-metformin
InsureWith Assistant
Hi! I can help you understand drug coverage, formulary tiers, prior authorization, and more. What would you like to know?